The risk or severity of adverse effects can be increased when promazine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when haloperidol is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when apomorphine is combined with captopril.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Apremilast.


The risk or severity of adverse effects can be increased when suprofen is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with clonidine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with propranolol.


The risk or severity of adverse effects can be increased when pramipexole is combined with spironolactone.


The risk or severity of adverse effects can be increased when furazolidone is combined with mirtazapine.


The risk or severity of adverse effects can be increased when L-phenylalanine is combined with leflunomide.


The risk or severity of adverse effects can be increased when zaleplon is combined with glutethimide.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with promethazine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with clonazepam.


The risk or severity of adverse effects can be increased when Melatonin is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Articaine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Melatonin.


The risk or severity of adverse effects can be increased when hexetidine is combined with barnidipine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with amisulpride.


The risk or severity of adverse effects can be increased when salicylic acid is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when lorazepam is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with acemetacin.


The risk or severity of adverse effects can be increased when barnidipine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Droxicam.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with carisoprodol.


The risk or severity of adverse effects can be increased when furosemide is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Butoconazole is combined with barnidipine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with amitriptyline.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Torasemide.


The risk or severity of adverse effects can be increased when Bortezomib is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Lurasidone.


The risk or severity of adverse effects can be increased when pirenzepine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when oxycodone is combined with levorphanol.


The risk or severity of adverse effects can be increased when methadone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when benzoic acid is combined with nicardipine.


The risk or severity of adverse effects can be increased when perphenazine is combined with halothane.


The risk or severity of adverse effects can be increased when fluoxetine is combined with loxapine.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Mirabegron.


The risk or severity of adverse effects can be increased when minoxidil is combined with nicardipine.


The risk or severity of adverse effects can be increased when tiapride is combined with Pizotifen.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when alprazolam is combined with atorvastatin.


The risk or severity of adverse effects can be increased when perphenazine is combined with thiamylal.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with sertraline.


The risk or severity of adverse effects can be increased when hydromorphone is combined with chlormezanone.


The risk or severity of adverse effects can be increased when ondansetron is combined with Perospirone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Salsalate.


The risk or severity of adverse effects can be increased when betamethasone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when zonisamide is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with zotepine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when diflunisal is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with ritonavir.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with propantheline.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with buspirone.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with oxycodone.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when nabumetone is combined with Clobetasone.


The risk or severity of adverse effects can be increased when SODIUM BICARBONATE is combined with misoprostol.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with captopril.


The risk or severity of adverse effects can be increased when orphenadrine is combined with Vecuronium.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Propiverine.


The risk or severity of adverse effects can be increased when levorphanol is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when cabergoline is combined with tiapride.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Retigabine.


The risk or severity of adverse effects can be increased when levorphanol is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when SOMATOSTATIN is combined with secobarbital.


The risk or severity of adverse effects can be increased when clozapine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when diflunisal is combined with equilin.


The risk or severity of adverse effects can be increased when tiagabine is combined with paroxetine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with trandolapril.


The risk or severity of adverse effects can be increased when sulindac is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Posaconazole is combined with vindesine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with efavirenz.


The risk or severity of adverse effects can be increased when amphotericin b is combined with reserpine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with primidone.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Perospirone.


The risk or severity of adverse effects can be increased when prazepam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Retigabine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Clevidipine.


The risk or severity of adverse effects can be increased when nabumetone is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when amifostine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when reserpine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when reserpine is combined with flurazepam.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with alclometasone.


The risk or severity of adverse effects can be increased when morphine is combined with nimodipine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with amisulpride.


The risk or severity of adverse effects can be increased when morphine is combined with sulpiride.


The risk or severity of adverse effects can be increased when procaine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when morphine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with doxazosin.


The risk or severity of adverse effects can be increased when bifonazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when reserpine is combined with tizanidine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with papaverine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with maprotiline.


The risk or severity of adverse effects can be increased when pramipexole is combined with propranolol.


The risk or severity of adverse effects can be increased when flurazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when thiamylal is combined with fexofenadine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when ketamine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Flupentixol is combined with bromazepam.


The risk or severity of adverse effects can be increased when enflurane is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when tetracaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with amisulpride.


The risk or severity of adverse effects can be increased when triazolam is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when cabergoline is combined with loxapine.


The risk or severity of adverse effects can be increased when methysergide is combined with metronidazole.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when HEROIN is combined with amisulpride.


The risk or severity of adverse effects can be increased when LISURIDE is combined with caffeine.


The risk or severity of adverse effects can be increased when nicergoline is combined with Quinupristin.


The risk or severity of adverse effects can be increased when benazepril is combined with salicylamide.


The risk or severity of adverse effects can be increased when pramipexole is combined with captopril.


The risk or severity of adverse effects can be increased when LISURIDE is combined with azithromycin.


The risk or severity of adverse effects can be increased when dicyclomine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when isoflurane is combined with etizolam.


The risk or severity of adverse effects can be increased when Dothiepin is combined with ritodrine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when tiapride is combined with dantrolene.


The risk or severity of adverse effects can be increased when hydromorphone is combined with efavirenz.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with Aliskiren.


The risk or severity of adverse effects can be increased when hydromorphone is combined with clorazepate.


The risk or severity of adverse effects can be increased when methysergide is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with nefazodone.


The risk or severity of adverse effects can be increased when Metipranolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Sitaxsentan.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when benztropine is combined with orphenadrine.


The risk or severity of adverse effects can be increased when azelastine is combined with diflunisal.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with tubocurarine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with rasagiline.


The risk or severity of adverse effects can be increased when Nabilone is combined with Aliskiren.


The risk or severity of adverse effects can be increased when methysergide is combined with Telithromycin.


The risk or severity of adverse effects can be increased when methysergide is combined with azelastine.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with gabapentin.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Normethadone.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with penbutolol.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when amifostine is combined with clomipramine.


The risk or severity of adverse effects can be increased when codeine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with butalbital.


The risk or severity of adverse effects can be increased when amifostine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when codeine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with felbamate.


The risk or severity of adverse effects can be increased when promethazine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when glutethimide is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when rapamycin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with etizolam.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with clomipramine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when mesoridazine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when HEROIN is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when diazepam is combined with Paliperidone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Etidocaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when desoximetasone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when Etomidate is combined with Retigabine.


The risk or severity of adverse effects can be increased when desoximetasone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when lorazepam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with Echothiophate.


The risk or severity of adverse effects can be increased when leflunomide is combined with medrysone.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with felbamate.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with norfloxacin.


The risk or severity of adverse effects can be increased when trandolapril is combined with alclofenac.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with xylometazoline.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with carvedilol.


The risk or severity of adverse effects can be increased when prazosin is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Asenapine is combined with cetirizine.


The risk or severity of adverse effects can be increased when oxycodone is combined with levodopa.


The risk or severity of adverse effects can be increased when procaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with physostigmine.


The risk or severity of adverse effects can be increased when trazodone is combined with procarbazine.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with memantine.


The risk or severity of adverse effects can be increased when lidocaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when procarbazine is combined with bupropion.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with amcinonide.


The risk or severity of adverse effects can be increased when fenbufen is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Asenapine is combined with glutethimide.


The risk or severity of adverse effects can be increased when NEOSTIGMINE is combined with Cevimeline.


The risk or severity of adverse effects can be increased when NEOSTIGMINE is combined with nicotine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with sertraline.


The risk or severity of adverse effects can be increased when Asenapine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Bortezomib is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when oxycodone is combined with butorphanol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when cilnidipine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when isoflurane is combined with dipyridamole.


The risk or severity of adverse effects can be increased when dyclonine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when propofol is combined with proparacaine.


The risk or severity of adverse effects can be increased when propofol is combined with Halazepam.


The risk or severity of adverse effects can be increased when dyclonine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when propofol is combined with indapamide.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Paliperidone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Paliperidone is combined with methylphenidate.


The risk or severity of adverse effects can be increased when Paliperidone is combined with triprolidine.


The risk or severity of adverse effects can be increased when secobarbital is combined with triprolidine.


The risk or severity of adverse effects can be increased when promazine is combined with ketamine.


The risk or severity of adverse effects can be increased when timolol is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when betamethasone is combined with edrophonium.


The risk or severity of adverse effects can be increased when benzocaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with galanthamine.


The risk or severity of adverse effects can be increased when Nabilone is combined with benazepril.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when flumethasone is combined with mefloquine.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with amoxapine.


The risk or severity of adverse effects can be increased when amoxapine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when dyclonine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when secobarbital is combined with methocarbamol.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Lofexidine.


The risk or severity of adverse effects can be increased when diclofenac is combined with tolmetin.


The risk or severity of adverse effects can be increased when diclofenac is combined with haloperidol.


The risk or severity of adverse effects can be increased when apomorphine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when ketamine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when dipyridamole is combined with salicylic acid.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Pramocaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when zaleplon is combined with duloxetine.


The risk or severity of adverse effects can be increased when tizanidine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when tropicamide is combined with Trospium.


The risk or severity of adverse effects can be increased when cilnidipine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when carprofen is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with Bretylium.


The risk or severity of adverse effects can be increased when methadone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when rasagiline is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Articaine is combined with imipramine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with paroxetine.


The risk or severity of adverse effects can be increased when enflurane is combined with tiapride.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when morphine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when suprofen is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when miconazole is combined with bepridil.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with promazine.


The risk or severity of adverse effects can be increased when NEOSTIGMINE is combined with Varenicline.


The risk or severity of adverse effects can be increased when acemetacin is combined with betamethasone.


The risk or severity of adverse effects can be increased when Naftifine is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when morphine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when triprolidine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when azelastine is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Almotriptan.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Lurasidone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when flurazepam is combined with nitrazepam.


The risk or severity of adverse effects can be increased when floctafenine is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Tavaborole is combined with nimesulide.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with flumethasone.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with flumethasone.


The risk or severity of adverse effects can be increased when terconazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when clotrimazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with mesoridazine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with maprotiline.


The risk or severity of adverse effects can be increased when losartan is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when triazolam is combined with Perospirone.


The risk or severity of adverse effects can be increased when ethanol is combined with Milnacipran.


The risk or severity of adverse effects can be increased when trandolapril is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when nilvadipine is combined with pramipexole.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Pentolinium is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with enflurane.


The risk or severity of adverse effects can be increased when glutethimide is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Remoxipride is combined with propoxyphene.


The risk or severity of adverse effects can be increased when triazolam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when thiamylal is combined with baclofen.


The risk or severity of adverse effects can be increased when mepivacaine is combined with clemastine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with methazolamide.


The risk or severity of adverse effects can be increased when mepivacaine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when clorazepate is combined with proparacaine.


The risk or severity of adverse effects can be increased when tropicamide is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when haloperidol is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with enalapril.


The risk or severity of adverse effects can be increased when nortriptyline is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when iohexol is combined with metformin.


The risk or severity of adverse effects can be increased when Tiludronic Acid is combined with Deferasirox.


The risk or severity of adverse effects can be increased when fosinopril is combined with terazosin.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Naftifine is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when clorazepate is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when betaxolol is combined with timolol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with enflurane.


The risk or severity of adverse effects can be increased when clorazepate is combined with Halazepam.


The risk or severity of adverse effects can be increased when zotepine is combined with Normethadone.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with fosinopril.


The risk or severity of adverse effects can be increased when floctafenine is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when glutethimide is combined with Retigabine.


The risk or severity of adverse effects can be increased when pergolide is combined with Capsaicin.


The risk or severity of adverse effects can be increased when olanzapine is combined with clonidine.


The risk or severity of adverse effects can be increased when Droxicam is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Droxicam is combined with Halobetasol.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Spirapril is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when sotalol is combined with methyldopa.


The risk or severity of adverse effects can be increased when sotalol is combined with apraclonidine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with Nebivolol.


The risk or severity of adverse effects can be increased when sotalol is combined with Telmisartan.


The risk or severity of adverse effects can be increased when floctafenine is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when methysergide is combined with irbesartan.


The risk or severity of adverse effects can be increased when triazolam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when morphine is combined with etizolam.


The risk or severity of adverse effects can be increased when triazolam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when bepridil is combined with cilnidipine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when benztropine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with omeprazole.


The risk or severity of adverse effects can be increased when Desloratadine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with dyclonine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with sulindac.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Sacubitril.


The risk or severity of adverse effects can be increased when Eprosartan is combined with chloroquine.


The risk or severity of adverse effects can be increased when chloroquine is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when scopolamine is combined with dantrolene.


The risk or severity of adverse effects can be increased when rasagiline is combined with apraclonidine.


The risk or severity of adverse effects can be increased when chloroquine is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with edrophonium.


The risk or severity of adverse effects can be increased when butabarbital is combined with trazodone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when butabarbital is combined with pentazocine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Iloperidone.


The risk or severity of adverse effects can be increased when buprenorphine is combined with theobromine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with meclizine.


The risk or severity of adverse effects can be increased when meperidine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with dexamethasone.


The risk or severity of adverse effects can be increased when naratriptan is combined with Pipamperone.


The risk or severity of adverse effects can be increased when betaxolol is combined with felodipine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with selegiline.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with meclizine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when betaxolol is combined with irbesartan.


The risk or severity of adverse effects can be increased when ramipril is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when amitriptyline is combined with isoetharine.


The risk or severity of adverse effects can be increased when acetazolamide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Phenelzine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when aspirin is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when nitrazepam is combined with butamben.


The risk or severity of adverse effects can be increased when cabergoline is combined with propoxyphene.


The risk or severity of adverse effects can be increased when ethosuximide is combined with tizanidine.


The risk or severity of adverse effects can be increased when valsartan is combined with Bretylium.


The risk or severity of adverse effects can be increased when ritodrine is combined with nylidrin.


The risk or severity of adverse effects can be increased when clozapine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when clozapine is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when cilazapril is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when mesalamine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when equilin is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when salicylamide is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when fluocinonide is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when cocaine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Butoconazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when dicyclomine is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when fluocinonide is combined with memantine.


The risk or severity of adverse effects can be increased when cilazapril is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when amiodarone is combined with Clofarabine.


The risk or severity of adverse effects can be increased when sotalol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when tolterodine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when Eprosartan is combined with ibuprofen.


The risk or severity of adverse effects can be increased when valsartan is combined with Apremilast.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with procaine.


The risk or severity of adverse effects can be increased when Halazepam is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when sertraline is combined with clomipramine.


The risk or severity of adverse effects can be increased when clozapine is combined with fosinopril.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when folinic acid is combined with 5-Fluorouracil.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with clozapine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with prednisone.


The risk or severity of adverse effects can be increased when Tramadol is combined with butabarbital.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with Metixene.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Tramadol is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Calcium citrate is combined with Doxercalciferol.


The risk or severity of adverse effects can be increased when Eplerenone is combined with hydralazine.


The risk or severity of adverse effects can be increased when sulfisoxazole is combined with Flibanserin.


The risk or severity of adverse effects can be increased when benzocaine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with ethotoin.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Tixocortol is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Echothiophate is combined with pilocarpine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with clozapine.


The risk or severity of adverse effects can be increased when fosinopril is combined with floctafenine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Icatibant.


The risk or severity of adverse effects can be increased when amisulpride is combined with primidone.


The risk or severity of adverse effects can be increased when halothane is combined with etizolam.


The risk or severity of adverse effects can be increased when Salsalate is combined with salicylamide.


The risk or severity of adverse effects can be increased when Lacidipine is combined with pravastatin.


The risk or severity of adverse effects can be increased when Rufinamide is combined with butabarbital.


The risk or severity of adverse effects can be increased when ropinirole is combined with indapamide.


The risk or severity of adverse effects can be increased when Tramadol is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when chloroxine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Sacubitril is combined with fenoprofen.


The risk or severity of adverse effects can be increased when clorazepate is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Sacubitril is combined with propranolol.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Nepafenac is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Sacubitril is combined with clonidine.


The risk or severity of adverse effects can be increased when ondansetron is combined with glutethimide.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Almotriptan.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when propantheline is combined with Trospium.


The risk or severity of adverse effects can be increased when zidovudine is combined with ribavirin.


The risk or severity of adverse effects can be increased when fluoxetine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when clorazepate is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when amisulpride is combined with triprolidine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with budesonide.


The risk or severity of adverse effects can be increased when amisulpride is combined with methocarbamol.


The risk or severity of adverse effects can be increased when amisulpride is combined with methylphenidate.


The risk or severity of adverse effects can be increased when Phenelzine is combined with zotepine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when mecamylamine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when temazepam is combined with nalbuphine.


The risk or severity of adverse effects can be increased when ramipril is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Sacubitril is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when promazine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with brotizolam.


The risk or severity of adverse effects can be increased when Pentolinium is combined with oxycodone.


The risk or severity of adverse effects can be increased when Vecuronium is combined with codeine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when lorazepam is combined with pentazocine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with enalapril.


The risk or severity of adverse effects can be increased when bumetanide is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when oxprenolol is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Tramadol is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Tramadol is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when apomorphine is combined with bepridil.


The risk or severity of adverse effects can be increased when cilazapril is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when apomorphine is combined with epoprostenol.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with perphenazine.


The risk or severity of adverse effects can be increased when lorazepam is combined with trazodone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with levorphanol.


The risk or severity of adverse effects can be increased when perphenazine is combined with clidinium.


The risk or severity of adverse effects can be increased when Apremilast is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when formestane is combined with decamethonium.


The risk or severity of adverse effects can be increased when Phenelzine is combined with isoetharine.


The risk or severity of adverse effects can be increased when Ramelteon is combined with doxepin.


The risk or severity of adverse effects can be increased when ganciclovir is combined with abacavir.


The risk or severity of adverse effects can be increased when lorazepam is combined with Normethadone.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with loteprednol.


The risk or severity of adverse effects can be increased when enflurane is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Cobicistat is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with bupivacaine.


The risk or severity of adverse effects can be increased when gabapentin is combined with nefazodone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Etomidate.


The risk or severity of adverse effects can be increased when barnidipine is combined with clonidine.


The risk or severity of adverse effects can be increased when barnidipine is combined with propranolol.


The risk or severity of adverse effects can be increased when antipyrine is combined with diflorasone.


The risk or severity of adverse effects can be increased when pramipexole is combined with Eprosartan.


The risk or severity of adverse effects can be increased when nalbuphine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Iloperidone.


The risk or severity of adverse effects can be increased when venlafaxine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with sulpiride.


The risk or severity of adverse effects can be increased when meperidine is combined with triamterene.


The risk or severity of adverse effects can be increased when fexofenadine is combined with clonazepam.


The risk or severity of adverse effects can be increased when tretinoin is combined with timolol.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when quetiapine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with propoxyphene.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Masoprocol is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with clonazepam.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with zonisamide.


The risk or severity of adverse effects can be increased when dipyridamole is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when loratadine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with ondansetron.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with cocaine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with tiagabine.


The risk or severity of adverse effects can be increased when cocaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Tavaborole is combined with nitrendipine.


The risk or severity of adverse effects can be increased when Escitalopram is combined with droperidol.


The risk or severity of adverse effects can be increased when methadone is combined with Normethadone.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Clobetasone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with tiapride.


The risk or severity of adverse effects can be increased when Propiverine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when chloroxine is combined with gabapentin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when pyridostigmine is combined with Varenicline.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with tiapride.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when fenoprofen is combined with diflunisal.


The risk or severity of adverse effects can be increased when indomethacin is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when linezolid is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with protriptyline.


The risk or severity of adverse effects can be increased when metolazone is combined with benazepril.


The risk or severity of adverse effects can be increased when Rufinamide is combined with cetirizine.


The risk or severity of adverse effects can be increased when Iloperidone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when pentobarbital is combined with dyclonine.


The risk or severity of adverse effects can be increased when suprofen is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Rufinamide is combined with glutethimide.


The risk or severity of adverse effects can be increased when tacrolimus is combined with mitomycin C.


The risk or severity of adverse effects can be increased when tacrolimus is combined with vindesine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with paramethasone.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with triprolidine.


The risk or severity of adverse effects can be increased when pimozide is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with benazepril.


The risk or severity of adverse effects can be increased when benazepril is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with alclofenac.


The risk or severity of adverse effects can be increased when barnidipine is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when epirizole is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with scopolamine.


The risk or severity of adverse effects can be increased when quinapril is combined with oxaprozin.


The risk or severity of adverse effects can be increased when gabapentin is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when benazepril is combined with Apremilast.


The risk or severity of adverse effects can be increased when sotalol is combined with propranolol.


The risk or severity of adverse effects can be increased when nabumetone is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when quinapril is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when butorphanol is combined with PAMABROM.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with disopyramide.


The risk or severity of adverse effects can be increased when clonidine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when baclofen is combined with duloxetine.


The risk or severity of adverse effects can be increased when baclofen is combined with fluoxetine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with carisoprodol.


The risk or severity of adverse effects can be increased when oxazepam is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Etidocaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when clonidine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Spirapril is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Lopinavir is combined with meperidine.


The risk or severity of adverse effects can be increased when morphine is combined with clorazepate.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when morphine is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when morphine is combined with nicardipine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when morphine is combined with efavirenz.


The risk or severity of adverse effects can be increased when Treprostinil is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with digitoxin.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Artemether is combined with Pregabalin.


The risk or severity of adverse effects can be increased when azelastine is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Articaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when pentazocine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Articaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Epirubicin.


The risk or severity of adverse effects can be increased when pentazocine is combined with levodopa.


The risk or severity of adverse effects can be increased when pentazocine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when zonisamide is combined with promethazine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with sertraline.


The risk or severity of adverse effects can be increased when chlortetracycline is combined with Acitretin.


The risk or severity of adverse effects can be increased when cetirizine is combined with paroxetine.


The risk or severity of adverse effects can be increased when butorphanol is combined with rasagiline.


The risk or severity of adverse effects can be increased when methadone is combined with clomipramine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with nimesulide.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with flunarizine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with citalopram.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Flupentixol.


The risk or severity of adverse effects can be increased when triflupromazine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when mecamylamine is combined with tubocurarine.


The risk or severity of adverse effects can be increased when pimozide is combined with butamben.


The risk or severity of adverse effects can be increased when protriptyline is combined with ethosuximide.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with captopril.


The risk or severity of adverse effects can be increased when amifostine is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Nabilone is combined with phentolamine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with ouabain.


The risk or severity of adverse effects can be increased when mecamylamine is combined with acebutolol.


The risk or severity of adverse effects can be increased when Olopatadine is combined with alclometasone.


The risk or severity of adverse effects can be increased when proparacaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when ticlopidine is combined with aspirin.


The risk or severity of adverse effects can be increased when bumetanide is combined with risperidone.


The risk or severity of adverse effects can be increased when brotizolam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when ATROPINE is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Apremilast is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Epirubicin is combined with clozapine.


The risk or severity of adverse effects can be increased when Melatonin is combined with HEROIN.


The risk or severity of adverse effects can be increased when thioridazine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with propofol.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with estrone.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with indapamide.


The risk or severity of adverse effects can be increased when quetiapine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when clozapine is combined with Perospirone.


The risk or severity of adverse effects can be increased when halothane is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when ethyl icosapentate is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Apremilast.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with butamben.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with budesonide.


The risk or severity of adverse effects can be increased when PARALDEHYDE is combined with citalopram.


The risk or severity of adverse effects can be increased when Etomidate is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when furosemide is combined with irbesartan.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when furosemide is combined with felodipine.


The risk or severity of adverse effects can be increased when furosemide is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when methadone is combined with Torasemide.


The risk or severity of adverse effects can be increased when captopril is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when rapamycin is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Etidocaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when captopril is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when captopril is combined with Droxicam.


The risk or severity of adverse effects can be increased when floctafenine is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when METAXALONE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when zopiclone is combined with butalbital.


The risk or severity of adverse effects can be increased when epirizole is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when thalidomide is combined with carvedilol.


The risk or severity of adverse effects can be increased when Telmisartan is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when prilocaine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Telmisartan is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when lithium ion is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when lithium ion is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when flurazepam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when LISURIDE is combined with PRIMAQUINE.


The risk or severity of adverse effects can be increased when imipramine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when thioridazine is combined with baclofen.


The risk or severity of adverse effects can be increased when rapamycin is combined with cyclosporin A.


The risk or severity of adverse effects can be increased when thioridazine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when resveratrol is combined with Apixaban.


The risk or severity of adverse effects can be increased when fenoldopam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when isoflurane is combined with betaxolol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Phenelzine.


The risk or severity of adverse effects can be increased when selegiline is combined with desipramine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Normethadone.


The risk or severity of adverse effects can be increased when Voriconazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when dibucaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Milnacipran.


The risk or severity of adverse effects can be increased when cilnidipine is combined with diltiazem.


The risk or severity of adverse effects can be increased when primidone is combined with thiopental.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Tapentadol.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when gabapentin is combined with thiopental.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when meprobamate is combined with clonazepam.


The risk or severity of adverse effects can be increased when oxprenolol is combined with trimipramine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when tirofiban is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when gabapentin is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when etizolam is combined with zonisamide.


The risk or severity of adverse effects can be increased when ibuprofen is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when topiramate is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when pyridostigmine is combined with methacholine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with citalopram.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when acebutolol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when reserpine is combined with minoxidil.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with rizatriptan.


The risk or severity of adverse effects can be increased when chlormezanone is combined with HEROIN.


The risk or severity of adverse effects can be increased when trazodone is combined with mepivacaine.


The risk or severity of adverse effects can be increased when buspirone is combined with butalbital.


The risk or severity of adverse effects can be increased when topotecan is combined with clozapine.


The risk or severity of adverse effects can be increased when thalidomide is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Ramelteon is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with sevoflurane.


The risk or severity of adverse effects can be increased when cetirizine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when quazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when nefazodone is combined with sulpiride.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when pirenzepine is combined with oxycodone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with tiapride.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with topiramate.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Clevidipine.


The risk or severity of adverse effects can be increased when levorphanol is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when levorphanol is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when butorphanol is combined with loratadine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with epirizole.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with irinotecan.


The risk or severity of adverse effects can be increased when butorphanol is combined with imipramine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with equilin.


The risk or severity of adverse effects can be increased when Clevidipine is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Lacidipine.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with theobromine.


The risk or severity of adverse effects can be increased when naratriptan is combined with Perospirone.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with cilnidipine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when trazodone is combined with glutethimide.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Olmesartan is combined with D-mannitol.


The risk or severity of adverse effects can be increased when haloperidol is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Phenelzine.


The risk or severity of adverse effects can be increased when valsartan is combined with ketorolac.


The risk or severity of adverse effects can be increased when Pipamperone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when haloperidol is combined with prazepam.


The risk or severity of adverse effects can be increased when haloperidol is combined with quazepam.


The risk or severity of adverse effects can be increased when haloprogin is combined with Amrinone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with thiamylal.


The risk or severity of adverse effects can be increased when imipramine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when metoprolol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Paliperidone is combined with halothane.


The risk or severity of adverse effects can be increased when haloperidol is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when codeine is combined with risperidone.


The risk or severity of adverse effects can be increased when Asenapine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when tropicamide is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Eplerenone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with bumetanide.


The risk or severity of adverse effects can be increased when Lurasidone is combined with meclizine.


The risk or severity of adverse effects can be increased when etodolac is combined with resveratrol.


The risk or severity of adverse effects can be increased when niflumic acid is combined with alclometasone.


The risk or severity of adverse effects can be increased when nefazodone is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with scopolamine.


The risk or severity of adverse effects can be increased when haloperidol is combined with baclofen.


The risk or severity of adverse effects can be increased when Pipamperone is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when levorphanol is combined with Agomelatine.


The risk or severity of adverse effects can be increased when clonidine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with labetalol.


The risk or severity of adverse effects can be increased when clonidine is combined with quinapril.


The risk or severity of adverse effects can be increased when haloperidol is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with ramipril.


The risk or severity of adverse effects can be increased when theophylline is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when cabergoline is combined with Caspofungin.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when alprazolam is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when levorphanol is combined with Etomidate.


The risk or severity of adverse effects can be increased when bromocriptine is combined with valsartan.


The risk or severity of adverse effects can be increased when levorphanol is combined with bupivacaine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when enflurane is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Olopatadine is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when salicylic acid is combined with nisoldipine.


The risk or severity of adverse effects can be increased when zotepine is combined with topiramate.


The risk or severity of adverse effects can be increased when mesalamine is combined with flumethasone.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when selegiline is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when paramethasone is combined with decamethonium.


The risk or severity of adverse effects can be increased when chloroquine is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when meperidine is combined with Almotriptan.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with ritodrine.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Amrubicin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with cytarabine.


The risk or severity of adverse effects can be increased when lisinopril is combined with tolmetin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with indapamide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with proparacaine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Halazepam.


The risk or severity of adverse effects can be increased when proparacaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when tolazoline is combined with tizanidine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when ketorolac is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when promethazine is combined with rasagiline.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with pimozide.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Mometasone.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with paroxetine.


The risk or severity of adverse effects can be increased when Echothiophate is combined with acetylcholine.


The risk or severity of adverse effects can be increased when fenbufen is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when niflumic acid is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when LISURIDE is combined with nitrendipine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with alclometasone.


The risk or severity of adverse effects can be increased when SULFALENE is combined with dapsone.


The risk or severity of adverse effects can be increased when morphine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with norfloxacin.


The risk or severity of adverse effects can be increased when resveratrol is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Quinupristin.


The risk or severity of adverse effects can be increased when isoflurane is combined with Pipamperone.


The risk or severity of adverse effects can be increased when propofol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when fosinopril is combined with dipyridamole.


The risk or severity of adverse effects can be increased when fosinopril is combined with azelastine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Ramelteon.


The risk or severity of adverse effects can be increased when triamterene is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Drospirenone.


The risk or severity of adverse effects can be increased when paroxetine is combined with rasagiline.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when nimodipine is combined with lisinopril.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with ketamine.


The risk or severity of adverse effects can be increased when thiothixene is combined with prazepam.


The risk or severity of adverse effects can be increased when butabarbital is combined with zopiclone.


The risk or severity of adverse effects can be increased when etizolam is combined with scopolamine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Cevimeline.


The risk or severity of adverse effects can be increased when metoclopramide is combined with nicotine.


The risk or severity of adverse effects can be increased when thiothixene is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with carisoprodol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when quazepam is combined with tiapride.


The risk or severity of adverse effects can be increased when QUINETHAZONE is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when midazolam is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when midazolam is combined with isoflurane.


The risk or severity of adverse effects can be increased when nicergoline is combined with sulfinpyrazone.


The risk or severity of adverse effects can be increased when midazolam is combined with prilocaine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when bepridil is combined with nicardipine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with baclofen.


The risk or severity of adverse effects can be increased when butamben is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when fenbufen is combined with diflorasone.


The risk or severity of adverse effects can be increased when metolazone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when tioconazole is combined with nisoldipine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Levocetirizine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when testosterone propionate is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when etizolam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when metoclopramide is combined with imipramine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Butethal is combined with Agomelatine.


The risk or severity of adverse effects can be increased when lidocaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when diazepam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with propofol.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with tiapride.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with 5-azacytidine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with acemetacin.


The risk or severity of adverse effects can be increased when diazepam is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when atenolol is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when tacrolimus is combined with BENZNIDAZOLE.


The risk or severity of adverse effects can be increased when nilvadipine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when procaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when zonisamide is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Articaine is combined with levodopa.


The risk or severity of adverse effects can be increased when proparacaine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when fenoprofen is combined with dexamethasone.


The risk or severity of adverse effects can be increased when cilazapril is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when atenolol is combined with felodipine.


The risk or severity of adverse effects can be increased when alclometasone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Dothiepin is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with D-mannitol.


The risk or severity of adverse effects can be increased when procyclidine is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when imipramine is combined with periciazine.


The risk or severity of adverse effects can be increased when gabapentin is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with trazodone.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with levodopa.


The risk or severity of adverse effects can be increased when olanzapine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when ondansetron is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when ondansetron is combined with fludiazepam.


The risk or severity of adverse effects can be increased when methazolamide is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when protriptyline is combined with desipramine.


The risk or severity of adverse effects can be increased when SIMEPREVIR is combined with oxycodone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with suprofen.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with primidone.


The risk or severity of adverse effects can be increased when bromazepam is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when enalapril is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when amoxapine is combined with periciazine.


The risk or severity of adverse effects can be increased when docetaxel is combined with amsacrine.


The risk or severity of adverse effects can be increased when Tianeptine is combined with Indacaterol.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with etizolam.


The risk or severity of adverse effects can be increased when ondansetron is combined with etizolam.


The risk or severity of adverse effects can be increased when dipyridamole is combined with terazosin.


The risk or severity of adverse effects can be increased when dyclonine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Isoconazole is combined with nifedipine.


The risk or severity of adverse effects can be increased when doxepin is combined with dobutamine.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when rapamycin is combined with ramipril.


The risk or severity of adverse effects can be increased when Pipamperone is combined with methyldopa.


The risk or severity of adverse effects can be increased when isradipine is combined with Bretylium.


The risk or severity of adverse effects can be increased when bumetanide is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with fosinopril.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Pipamperone is combined with apraclonidine.


The risk or severity of adverse effects can be increased when risperidone is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when benztropine is combined with HEROIN.


The risk or severity of adverse effects can be increased when halothane is combined with Torasemide.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Escitalopram.


The risk or severity of adverse effects can be increased when flurazepam is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when irbesartan is combined with nifedipine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with moclobemide.


The risk or severity of adverse effects can be increased when methocarbamol is combined with imipramine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when isoflurane is combined with nitrazepam.


The risk or severity of adverse effects can be increased when secobarbital is combined with thiopental.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with diflorasone.


The risk or severity of adverse effects can be increased when tolterodine is combined with topiramate.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Paliperidone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when benzocaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with tiagabine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with cocaine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with maprotiline.


The risk or severity of adverse effects can be increased when Mometasone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with zonisamide.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Almotriptan.


The risk or severity of adverse effects can be increased when niflumic acid is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when benazepril is combined with quetiapine.


The risk or severity of adverse effects can be increased when Normethadone is combined with clidinium.


The risk or severity of adverse effects can be increased when oxycodone is combined with spironolactone.


The risk or severity of adverse effects can be increased when oxycodone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when clidinium is combined with Desloratadine.